A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. - Wikidata - awgldk - TriplyDB

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

http://www.wikidata.org/entity/Q35559573

about

Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation Plasma transfusion strategies for critically ill patients Plasma transfusion strategies for critically ill patients Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document Prophylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?Evidence and triggers for the transfusion of blood and blood products Haemostatic management of cardiac surgical haemorrhage A 2014 Update on Coagulation Management for Cardiopulmonary Bypass.Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).The management of abnormal haemostasis in the ICU.Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease.Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational study The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice.The conundrum of persistent inappropriate use of frozen plasma.Successful implementation of a packed red blood cell and fresh frozen plasma transfusion protocol in the surgical intensive care unit Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis.Adverse effects of plasma transfusion Plasma transfusions prior to insertion of central lines for people with abnormal coagulation.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort study.Outcomes of patients with rodenticide poisoning at a far east poison center.Severe sepsis and septic shock: management and performance improvement.Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.Controversies in the use of fresh frozen plasma in critically ill small animal patients.Risk of Procedural Hemorrhage.Image-guided intervention in the coagulopathic patient.Factors influencing plasma transfusion practices in paediatric intensive care units around the world.Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials.Prophylactic Plasma Transfusion Is Not Associated With Decreased Red Blood Cell Requirements in Critically Ill Patients.How we manage AB plasma inventory in the blood center and transfusion service.Changing trends in blood transfusion: an analysis of 244,013 hospitalizations.Association between plasma transfusions and clinical outcome in critically ill children: a prospective observational study.The effect of fresh frozen plasma in critically ill patients.Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study.Changes in colloid solution sales in Nordic countries.Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.Prophylactic plasma transfusion for patients undergoing non-cardiac surgery.

P2860

Q24187500-A3B8CE85-0B6C-4020-847D-4734C1E550F9 Q24201589-28478643-43EF-49B6-BF0E-8E7EA1ADA477 Q24201609-4A4FE1F2-0B60-4336-BA25-D8B84A217C3A Q26748355-3CA05167-20E1-4ADE-92C2-975F055343CD Q27001075-DED83AD9-2277-4AEE-B36B-12180FD0EEE8 Q27008573-13AF67B4-4D71-4044-938E-C13F32E3299D Q27024386-1C762149-2F8A-4BB2-A5D6-7A6EEFC5F563 Q30458252-69CE2384-28AB-45DC-8CE7-583CBA214A09 Q33403000-5FD4499F-BAA8-477F-821F-480131512F73 Q33415825-79C2D8E3-391F-429A-A836-753044BCBB75 Q33418970-D8058220-6DED-49B4-8A4A-7DEDC0DFCF1D Q33435884-22F546C1-029B-4273-8877-68B0DE760181 Q34132303-1D31128D-0586-4891-9FF3-21C9FDBEF0B5 Q35106675-3B26AE79-1A06-472A-8CFA-1A32643FC8B5 Q35430725-644354E4-7741-40F0-892D-DD7DBB7D7CC8 Q35558167-0631E202-A9C6-40FC-8991-CDD0382E0469 Q35641141-466A495A-8685-41C9-A34C-A87C6CC031C1 Q35772078-C8DCAAFD-E92E-490F-A5B9-04CC379A7418 Q35778313-113526CE-C1D5-4648-BCAB-14B17DC7767B Q35972184-5A98FBFC-229A-47E1-AD81-6AFF415EF97D Q36137840-5861DEE0-C368-43D4-9B25-3E46D61DE78A Q36760558-C74509C2-F04E-443D-97EF-7B1F29111807 Q37226004-DFF0CF95-A3DF-45AE-AD39-6DCF92B01F0B Q37562996-94EC82BB-ECD4-45F0-9C1C-B1D157929D31 Q38009414-0674650E-2062-4387-82C5-A027F70622D5 Q38325203-6E3D39FD-96F1-4975-8B49-B5658DE9EAD6 Q38719988-6DAE5346-1E9B-4A98-A44A-90A3D7A975A5 Q38750017-48F7DA68-EF08-43EB-90DC-946CCB782DCD Q38972866-0690C62A-8E82-41AA-97CE-52CB8C91CBDD Q39132227-991536A7-C4F0-4164-8F72-63477898C3EB Q40342989-15B5BCD5-2683-411C-99F4-DEE6B36EE48D Q43659698-210DEB89-1B12-4B98-8F0B-47C4E98DFC41 Q44337668-204F837F-FCAA-41F4-97AD-8A1F2F6AD78C Q44378745-C2AB30F5-61D3-4A66-8DF9-9450467201BD Q45866452-912A175B-B3E4-4530-A259-5D1DF2CB68CA Q45872457-9E6AA30F-EE95-4AD8-82D7-0B6E61AD102C Q46734739-11D71B2E-04AA-4962-AE52-789CDCC6FB40 Q47190025-2735348A-1DA4-48F4-B116-9F4CFDCD4CD2 Q47220914-7330EED4-09CF-4A8D-8981-24BC81D457E8 Q47229511-4F05B43E-5E7D-4C5B-AC2B-B4321D9508BB

P2860

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

http://www.wikidata.org/entity/Q35559573

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A national study of plasma use ...... nd effect on prothrombin time.

@ast

A national study of plasma use ...... nd effect on prothrombin time.

@en

type

label

A national study of plasma use ...... nd effect on prothrombin time.

@ast

A national study of plasma use ...... nd effect on prothrombin time.

@en

prefLabel

A national study of plasma use ...... nd effect on prothrombin time.

@ast

A national study of plasma use ...... nd effect on prothrombin time.

@en

P1433

Q35559573-D45AFC73-6A1A-44D8-B51B-787CED80918F

P1476

Q35559573-969ED50F-BEAC-46AE-8AEE-7E5B9D5314E3

P2093

Q35559573-41E20F3B-F2B1-4BDA-8452-46A8A79FD923

Q35559573-6DA29528-047A-4E7D-AC2A-7414330EC568

Q35559573-70FC86C2-08DC-4F83-8855-EEE985E005A1

Q35559573-71B24F21-CD6F-4EAA-BEF4-015E3183B3C8

Q35559573-88EB0715-CDF0-4F29-907A-41015CE619C4

Q35559573-B8DD9685-0A00-4518-B2D7-3D21FC7616E8

Q35559573-CDB9E087-05A8-4BA0-A652-FDB3B9A2C270

P2860

Q35559573-034646C1-BDD5-4177-B310-3AE56A632928

Q35559573-053F4300-72D9-48D8-B693-7C6D038C6473

Q35559573-06438B5E-3A46-47DF-AB55-16954CCC4B6F

Q35559573-0E61EA5C-3BA0-4143-A30C-32E2A99E9196

Q35559573-100DE26F-3DBA-4B43-A15E-A82CBC0A3F45

Q35559573-15A94729-5DF7-43D1-A06D-E2F00816E66F

Q35559573-1663E43A-3736-49EC-B501-71B97E1B6226

Q35559573-21846B91-DC12-407A-9C96-E5081C1A0D8D

Q35559573-4323A425-E88E-4BE5-AFE9-FA219FBC9326

Q35559573-43F05F7B-79D1-4582-A172-F67060C3A7A9

P2888

Q35559573-07E64897-9645-4BDB-B6A5-98D540FA6CB0

P304

Q35559573-B009EEE4-3FF1-428F-82CF-B2209CAEF549

P31

Q35559573-3DC5FB35-4594-445D-9AEB-DBEC2351E3FC

P356

Q35559573-D443DFFD-C306-4CC1-9F8D-FA9EB53C2746

P433

Q35559573-C0D3E0F3-0C22-4EA1-A605-2CE31BCB9D55

P478

Q35559573-2FC7FBA5-6186-4097-AAD0-1BBF1CC63834

P577

Q35559573-EC4DFEB7-4B1F-433A-8E2E-633A9EFEC700

P5875

Q35559573-37D71091-5254-42C8-B9CE-291ECBB448B0

P6179

Q35559573-A68EE3B5-744A-42E2-B91B-90058E448759

P698

Q35559573-F6719EA8-9A36-419D-8FF7-E523D08209AA

P932

Q35559573-1BA1EF53-B671-44AB-87F7-9A51E4AE4650

P356

P1433

P1476

A national study of plasma use ...... nd effect on prothrombin time.

@en

P2093

Douglas M Watson

http://www.w3.org/2001/XMLSchema#string

Duncan Wyncoll

http://www.w3.org/2001/XMLSchema#string

Intensive Care Study of Coagulopathy (ISOC) investigators

http://www.w3.org/2001/XMLSchema#string

Robert J Lee

http://www.w3.org/2001/XMLSchema#string

Robin J Prescott

http://www.w3.org/2001/XMLSchema#string

Simon J Stanworth

http://www.w3.org/2001/XMLSchema#string

Timothy S Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?

Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.

The incidence and cause of coagulopathies in an intensive care population.

Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients

Duration of red-cell storage and complications after cardiac surgery.

Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.

Fatalities caused by TRALI.

Predicting hemorrhage using preoperative coagulation screening assays.

Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review.

P2888

P304

R108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC10129

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51019520

http://www.w3.org/2001/XMLSchema#string

P6179

1030030100

http://www.w3.org/2001/XMLSchema#string

P698

21466676

http://www.w3.org/2001/XMLSchema#string

P932

3219386

http://www.w3.org/2001/XMLSchema#string